Source: Annual Congress 2009 - Methodological aspects of asthma and COPD epidemiology
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. Braut, T. M. L. Eagan, M. Voll-Aanerud, J. A. Hardie, T. Wentzel-Larsen, P. S. Bakke (Bergen, Norway). Non-response in a COPD exacerbation study. Eur Respir J 2009; 34: Suppl. 53, 1005

Member's Comments

No comment yet.

Related content which might interest you: Predictors of non-response in a COPD exacerbation study Source: Annual Congress 2010 - Methods in respiratory epidemiology Year: 2010 An observational study of risk factors for hospitalization of chronic obstructive pulmonary disease exacerbation and their outcome Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 Impact of age-related comorbidities on the risk of COPD exacerbations in subjects with severe airflow limitation: A pan-European study Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Methodologies for study of COPD exacerbations Source: Annual Congress 2012 - ERS COPD exacerbation guidelines: methodologies and overview Year: 2012 Rehospitalizations for an acute exacerbation among patients with COPD Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 The impact of bronchiectasis on outcomes in a large cohort of patients hospitalised with exacerbations of COPD Source: Annual Congress 2013 –Treating bronchiectasis in respiratory patients Year: 2013 Polypharmacy in patients with acute exacerbation of COPD Source: Annual Congress 2011 - COPD management Year: 2011 An evaluation of exacerbations in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 89s Year: 2004 A global survey conducted to determine frequency of exacerbations in COPD patients Source: Annual Congress 2013 –COPD treatment Year: 2013 A retrospective cohort study demonstrating the impact of an OPEP device on exacerbations in COPD patients with chronic bronchitis Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 COPD patients with asthma, characteristics and risk of exacerbations Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 Risk factors for another hospitalization in COPD patients hospitalized for exacerbation Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 Statins and outcome of COPD patients after hospitalization for COPD exacerbations Source: Annual Congress 2010 - New treatments for asthma and COPD Year: 2010 Baseline characteristics of COPD patients with frequent COPD exacerbations in tiotropium trials Source: Eur Respir J 2006; 28: Suppl. 50, 175s Year: 2006 β-blockers and risk of COPD exacerbation requiring hospitalisation in patients with COPD Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011 Lung function change and exacerbations in patients with COPD in the WISDOM study Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015 Characterisation of COPD exacerbations. The ECOS study Source: Annual Congress 2009 - COPD: exacerbation and clinical problems Year: 2009 QVA149 reduces COPD exacerbation rate in various subgroups of patients: The SPARK study Source: Annual Congress 2013 –New bronchodilators for COPD management Year: 2013 Association of COPD inhaled  medication adherence with hospitalization for acute exacerbation of COPD (AECOPD) Source: International Congress 2017 – COPD management Year: 2017 Exacerbation of respiratory symptoms in COPD patients may not be exacerbations of COPD Source: Eur Respir J 2013; 41: 993-995 Year: 2013